Research Identifies Lung Cancer in Women as Distinct Disease

Emergence of a Distinct Disease

Recent scientific research has identified that lung cancer in women emerges as a distinct disease compared to the version found in men. This distinction suggests that the biological drivers and manifestations of the cancer differ based on sex, which may necessitate a shift in how the disease is diagnosed and treated.

While lung cancer has historically been perceived as a disease that predominantly affects men, recent epidemiological data indicate an increasing number of diagnoses among women. This shift is particularly evident in certain regions; for example, in France, lung cancer has become the third most commonly diagnosed cancer among women, with more than 19,000 new cases reported annually.

Diverging Trends in Incidence

Data shows a divergence in the incidence rates of the disease between genders. While the incidence of lung cancer is decreasing in men, it continues to rise in women. This trend is not limited to France but is also observed across other European countries.

Specific demographic groups are facing higher risks despite the absence of traditional risk factors. Asian American and Latina women who have never smoked are experiencing higher rates of lung cancer. A 2023 study noted that while rates of the disease have been decreasing in every other group, these specific populations remain vulnerable.

Challenges in Screening and Diagnosis

Despite the rising burden, current screening protocols are often too narrow to capture all at-risk women. Because screenings are frequently tied to smoking history, many women—particularly those who have never smoked—are missed during early detection phases,.

This gap in screening can lead to delayed diagnoses and advanced-stage discoveries. In one reported account, a 42-year-old woman in California reported that doctors dismissed her early symptoms for months, misdiagnosing her with pneumonia before she was eventually diagnosed with stage 4 lung cancer.

Treatment Resistance and Biological Complexity

Adding to the complexity of treatment is the ability of lung cancer cells to adapt. Research published in *Molecular Oncology* on May 27 reveals that lung cancer cells can change their identity to resist medical treatments. These cells can become more aggressive and harder to treat by reactivating biological processes involved in early lung development.